RS
PROK icon

R Squared’s ProKidney PROK Stock Holding History

R Squared’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5K Buy
+13,696
New +$29.1K 0.01% 456

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

R Squared's PROK Position: Q1 2026 in Review

R Squared opened a new position in ProKidney (PROK) in Q1 2026: 13,696 shares worth $24.5K. The stake represents 0.01% of the portfolio and ranks #456 among its holdings.

71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • R Squared held 13,696 shares of ProKidney worth $24.5K as of Q1 2026.
  • ProKidney was a new R Squared position in Q1 2026.
  • ProKidney made up 0.01% of R Squared's portfolio in Q1 2026, its #456 holding.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.